rs373384814

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_152594.3(SPRED1):​c.446G>A​(p.Ser149Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000353 in 1,613,876 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00037 ( 7 hom. )

Consequence

SPRED1
NM_152594.3 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.50
Variant links:
Genes affected
SPRED1 (HGNC:20249): (sprouty related EVH1 domain containing 1) The protein encoded by this gene is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. The encoded protein can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0063229203).
BP6
Variant 15-38339759-G-A is Benign according to our data. Variant chr15-38339759-G-A is described in ClinVar as [Benign]. Clinvar id is 468798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-38339759-G-A is described in Lovd as [Likely_benign]. Variant chr15-38339759-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000171 (26/152286) while in subpopulation SAS AF= 0.00497 (24/4830). AF 95% confidence interval is 0.00343. There are 0 homozygotes in gnomad4. There are 18 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 26 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPRED1NM_152594.3 linkuse as main transcriptc.446G>A p.Ser149Asn missense_variant 5/7 ENST00000299084.9 NP_689807.1 Q7Z699

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPRED1ENST00000299084.9 linkuse as main transcriptc.446G>A p.Ser149Asn missense_variant 5/71 NM_152594.3 ENSP00000299084.4 Q7Z699
SPRED1ENST00000561317.1 linkuse as main transcriptc.383G>A p.Ser128Asn missense_variant 6/64 ENSP00000453680.1 H0YMN8

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152168
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00496
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000825
AC:
207
AN:
250830
Hom.:
4
AF XY:
0.00109
AC XY:
148
AN XY:
135556
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00663
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000372
AC:
543
AN:
1461590
Hom.:
7
Cov.:
39
AF XY:
0.000525
AC XY:
382
AN XY:
727084
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00573
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000989
Gnomad4 OTH exome
AF:
0.000596
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152286
Hom.:
0
Cov.:
32
AF XY:
0.000242
AC XY:
18
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00497
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.0000931
Hom.:
0
Bravo
AF:
0.0000378
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000931
AC:
113
Asia WGS
AF:
0.00375
AC:
13
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxFeb 01, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 03, 2021- -
Legius syndrome Benign:2
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 17, 2017Variant summary: The SPRED1 c.446G>A (p.Ser149Asn) variant involves the alteration of a conserved nucleotide. The variant lies within the WH1/EVH1 domain and the PH domain-like domain (InterPro). 4/4 in silico tools predict a benign outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in the large control database ExAC in 113/123230 control chromosomes of all ethnicities, but was predominantly observed in the South Asian subpopulation at a frequency of 0.006663 (110/16510 with 3 homozygotes). This frequency is about 2665 times the estimated maximal expected allele frequency of a pathogenic SPRED1 variant (0.0000025), providing strong evidence that this is likely a benign polymorphism found primarily in the populations of South Asian origin. Two studies identified the variant in patient cohorts, one of which identified an unaffected father of the proband carrying the variant, showing lack of cosegregation (Messiaen_JAMA_2009). Additionally, functional studies that measured inhibition of MEK, ERK activation, FGF-induced Elk1 activation, Raf1 kinase activity and phosphorylation, and effect this variant on differentiation of PC12 cells show that this variant behaves similar to the WT control, in contrary to several truncating mutations also tested, suggesting the variant has no significant functional effect (Brems_Nat Genet_2007, Messiaen_JAMA_2009). Taken together, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Benign
0.19
T;T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.056
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.61
T;T
MetaRNN
Benign
0.0063
T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Uncertain
2.5
M;.
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.19
Sift
Benign
0.27
T;D
Sift4G
Benign
0.17
T;T
Polyphen
0.0010
B;.
Vest4
0.29
MVP
0.72
MPC
0.32
ClinPred
0.040
T
GERP RS
3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.097
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs373384814; hg19: chr15-38631960; API